Dental implant firm announces IPO terms

BioHorizons, a manufacturer of dental implants, said it expects to raise $90 million by offering 5.6 million shares at a price range of $15 to $17 in its initial public offering (IPO).

At the midpoint of the proposed range, BioHorizons will command a market value of $315 million, according to a news brief from Renaissance Capital.

The company originally filed for its IPO in June 2010. The IPO is expected to price during the week of January 31, according to Renaissance.

BioHorizons, which was founded in 1995 and booked $78 million in sales for the 12 months ended September 30, 2010, plans to list on the Nasdaq under the symbol BHZN.

Copyright © 2011

Page 1 of 272
Next Page